Recent studies have demonstrated that CDK4/6 inhibitors effectively reduced cell proliferation and tumor growth in several brain tumors, including GBMs [8,9,10,11], AT/RTs [12], medulloblastomas [13,14] and ependymomas [15]. The gene discussed is CDK4; the disease is neoplasm.